Brain function in Duchenne muscular dystrophy

Brain

Volumn 125, Issue 1, 2002, Pages 4-13

  Anderson, J L ^a   Head, S I ^a   Rae, C ^b   Morley, J W ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

CNS; Dystrophin; Mdx

Indexed keywords

DYSTROPHIN;

BIOENERGY; BRAIN ELECTROPHYSIOLOGY; COGNITIVE DEFECT; HEREDITARY SPINAL MUSCULAR ATROPHY; HIPPOCAMPUS; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; REVIEW;

EID: 0036156243     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awf012     Document Type: Review

References (112)

1. Etiology of intellectual impairment in Duchenne muscular dystrophy
2. Mental retardation in association with progressive dystrophy
3. Serial position memory of boys with Duchenne muscular dystrophy
4. Head circumference and intellectual performance of patients with Duchenne muscular dystrophy
5. In vitro erythrocyte water transport in Duchenne muscular dystrophy: An NMR investigation
6. Segregation analysis of 1885 DMD families. Significant departure from the expected proportion of sporadic cases
7. Electroencephalographic studies in hereditary myopathy
8. Inhibition of N-acetylaspartate production. Implications for 1H MRS studies in vivo
9. Reading ability and processing in Duchenne muscular dystrophy and spinal muscular atrophy
10. Intellectual ability as related to age and stage of disease in muscular dystrophy: A brief note
11. The neurobiology of Duchenne muscular dystrophy: Learning lessons from muscle?
12. Homologies between membrane proteins result in expected or unexpected relation between neuromuscular and erythrocyte diseases
13. Cognitive impairment in Duchenne muscular dystrophy
14. X chromosome-linked muscular dystrophy (mdx) in the mouse
15. Genetic and clinical correlations of Xp21 muscular dystrophy
16. The organisation of spinal projecting brainstem neurons in an animal model of muscular dystrophy: A retrograde tracing study on mdx mutant mice
17. Varieties of developmental dyslexia
18. A novel deletion of the dystrophin S-promoter region co-segregating with mental retardation
19. The genetic relationship of progressive muscular dystrophy (Duchenne type) and mental retardation
20. Lobular patterns of cerebellar activation in verbal working-memory and finger-tapping tasks as revealed by functional MRI
21. Functional involvement of cerebral cortex in Duchenne muscular dystrophy
22. Language and learning disorders of older boys with Duchenne muscular dystrophy
23. Intellectual impairment in muscular dystrophy
24. Involvement of the nervous system in muscular dystrophies in man
25. The central nervous system in Duchenne muscular dystrophy
26. Recherches sur la paralysie musculaire pseudo-hypertrophique, ou paralysie myo-sclerosique
27. Dystrophin and the integrity of the sarcolemma in Duchenne muscular dystrophy
28. Population frequencies of inherited neuromuscular diseases - A world survey
29. Effects of intramembrane particle aggregation on erythrocyte membrane fluidity: An electron spin resonance study in normal and in dystrophic subjects
30. Intelligence levels of patients with the Duchenne type of progressive muscular dystrophy (pmd-d)
31. Aquaporin-4 deficiency in skeletal muscle and brain of dystrophic mdx mice
32. Hippocampal LTP in dystrophin and dystrophin-isoforms deficient mice
33. 3cv)
34. Metabolic profiling of genetic disorders: A multitissue 1H nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue
35. Membrane potential, resting calcium and calcium transients in isolated muscle fibres from normal and dystrophic mice
36. Abnormalities in structure and function of limb skeletal muscle fibres of dystrophic mdx mice
37. Poor verbal working memory across intellectual level in boys with Duchenne dystrophy
38. Multifocal glial nodules in a case of Duchenne muscular dystrophy with severe mental retardation
39. Timing functions of the cerebellum
40. Brain morphology in Duchenne muscular dystrophy: A Golgi study
41. Motor sequence learning: A study with positron emission tomography
42. GABAA receptor pharmacology
43. Does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI
44. Intellectual functioning in Duchenne muscular dystrophy: A review
45. IQ studies in Duchenne muscular dystrophy II: Test-retest performance
46. Early verbal disability in children with Duchenne muscular dystrophy
47. Analysis of verbal disability in Duchenne muscular dystrophy
48. Increased cerebral choline-compounds in Duchenne muscular dystrophy
49. A receptors in mice lacking dystrophin (mdx mice)
50. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals
51. Mental retardation in patients with Duchenne progressive muscular dystrophy
52. Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion
53. A receptors in the regulation of sleep: Initial sleep responses to peripherally administered modulators and agonists
54. Intellect and behaviour in Duchenne muscular dystrophy
55. Point mutations at the carboxy terminus of the human dystrophin gene: Implications for an association with mental retardation in DMD patients
56. Neuropsychological consequences of cerebellar tumour resection in children. Cerebellar cognitive affective syndrome in a paediatric population
57. Dystrophin in the nervous system
58. Psychological aspects of some chronic progressive neuromuscular disorders. 1. Cognitive abilities
59. Evidence for early impairment of verbal intelligence in Duchenne muscular dystrophy
60. Brain dystrophin, neurogenetics and mental retardation
61. Enhanced sensitivity of hippocampal pyramidal neurons from mdx mice to hypoxia-induced loss of synaptic transmission
62. Decreased osmotic stability of dystrophinless muscle cells from the mdx mouse
63. Mechanism of CO2 retention in patients with neuromuscular disease
64. Severe cognitive impairment in DMD: Obvious clinical indication for Dp71 isoform point mutation screening
65. The psychosocial factors in muscular dystrophy
66. A receptor activation attenuates excitotoxicity but exacerbates oxygen-glucose deprivation-induced neuronal injury in vitro
67. Passive avoidance behaviour deficit in the mdx mouse
68. Nervous system involvement in progressive muscular dystrophy
69. Association of abnormal cerebellar activation with motor learning difficulties in dyslexic adults
70. Electroencephalogram and myopathy. Relation between muscular dystrophy and related diseases
71. Clinical significance of 14 and 6 per second positive spike complexes
72. Intelligence and the gene for Duchenne muscular dystrophy
73. Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells
74. Metabolic abnormalities in the mdx mouse brain
75. Brain biochemistry in Duchenne muscular dystrophy: A 1H magnetic resonance and neuropsychological study
76. Metabolic abnormalities in the developmental dyslexia detected by 1H magnetic resonance spectroscopy
77. Brain biochemical abnormalities associated with lack of dystrophin; studies in the mdx mouse
78. Apparent association of mental retardation and specific patterns of deletions screened with probes cf56a and cf23a in Duchenne muscular dystrophy
79. Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy
80. Sleep patterns in nonambulatory boys with Duchenne muscular dystrophy
81. Erythrocyte spectrin peak II phosphorylation in Duchenne muscular dystrophy
82. Membrane protein kinase alteration in Duchenne muscular dystrophy
83. The cerebral defect and myopathy in Duchenne muscular dystrophy. A comparative and clinicopathological study
84. Mental deficiency associated with muscular dystrophy. A neuropathological study
85. Architectural changes of the cortico-spinal system in the dystrophin defective mdx mouse
86. Increased head circumference in patients with Duchenne muscular dystrophy
87. Emotional reactions in muscular dystrophy
88. Le développement mental dans dystrophie musculaire de Duchenne. Correlation avec les données du scanner cérébral
89. Decreased water permeability of erythrocyte membranes in patients with Duchenne muscular dystrophy
90. Spatial learning and hippocampal long-term potentiation are not impaired in mdx mice
91. Reactions observed in boys of various ages (ten to fourteen) to a crippling, progressive, and fatal illness (muscular dystrophy)
92. Early development of boys with Duchenne muscular dystrophy
93. Neuropsychological impairment in Duchenne muscular dystrophy
94. Mechanism and regulation of swelling-activated inositol efflux in brain glial cells
95. Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease
96. The mutant mdx: Inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates
97. Brain abnormalities in Duchenne muscular dystrophy: Phosphorus-31 magnetic resonance spectroscopy and neuro-psychological study
98. Brain metabolism is abnormal in the mdx model of Duchenne muscular dystrophy
99. An in vivo and in vitro 1H-magnetic resonance spectroscopy study of mdx mouse brain: Abnormal development or neural necrosis?
100. Personal and social adjustments of children with muscular dystrophy
101. Influence of dystrophin-gene mutation on mdx mouse behavior. I. Retention deficits at long delays in spontaneous alternation and bar-pressing tasks
102. 3cv mice lacking dystrophin gene products
103. Facilitated NMDA receptor-mediated synaptic plasticity in the hippocampal CA1 area of dystrophin-deficient mice
104. On the classification, natural history and treatment of the myopathies
105. Clinical and EEG observations in patients with progressive muscular dystrophy
106. Intellectual function in childhood progressive muscular dystrophy
107. Mitochondrial calcium overload: A general mechanism for cell necrosis in muscle diseases
108. Central nervous system involvement in progressive muscular dystrophy
109. Psychometric studies in muscular dystrophy type 3a (Duchenne)
110. Central nervous system manifestations in childhood muscular dystrophy (CMD). I. Psychometric and electroencephalographic findings